🔎 Trials Near Me

Akèy › Gliyòm › Washington

Etid klinik pou Gliyòm nan Washington

11 etid pou Gliyòm ap chèche patisipan nan sit nan Washington.

Vil nan Washington

Tèks ofisyèl etid la (Anglè)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
Ap rekriteFaz 1/2
12 Months – 21 Years · Tout sèks · Mizajou Oct 1, 2026 · NCT05099003

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Seattle Children's Hospital, Seattle
Ap rekriteFaz 2
12 Months – 39 Years · Tout sèks · Mizajou Sep 21, 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

  • Seattle Children's Hospital, Seattle
Ap rekriteEtid obsèvasyon
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Seattle Children's Hospital, Seattle
Ap rekriteFaz 2
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Fred Hutch Cancer Center, Seattle
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Seattle Children's Hospital, Seattle
Ap rekriteFaz 2
Laj 3 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • University of Washington School of Medicine, Seattle
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Seattle Children's Hospital, Seattle
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 1 a 21 · Tout sèks · Mizajou Jun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Seattle Children's Hospital, Seattle
Ap rekriteFaz 2
12 Months – 39 Years · Tout sèks · Mizajou May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Seattle Children's Hospital, Seattle
Ap rekriteFaz 1 bonè
Jiska laj 21 · Tout sèks · Mizajou Mar 18, 2026 · NCT04655404

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.